Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Phase 1B Open-Label, Single Ascending Dose Clinical Trial Designed to Evaluate the Safety of Two Dose Levels of Light-activated AU-011 for the Treatment of Subjects With Small to Medium Primary Chor
Brief Summary: The primary objective is to assess the safety, immunogenicity and preliminary efficacy of a single treatment of one of two dose levels of Light-activated AU-011 for the treatment of subjects with primary choroidal melanoma.